肝纤维化动物模型的功能磁共振定量研究及部分临床应用
|
摘要
第一部分肝纤维化实验模型的建立
目的构建稳定、可靠、肝纤维化实验动物模型,研究模型肝脏病变的进展情况和常规影像学表现,为影像学功能成像定量评价做准备。
方法50只雄性清洁级Sprague-Dawley鼠,30只普通级雄性新西兰大白兔,随机分为实验组(新西兰大白兔n=20；SD大鼠n=40)和对照组(新西兰大白兔n=10;SD大鼠n=10)。采用CCL4(四氯化碳)腹腔注射法诱导肝纤维化鼠模型,血吸虫尾蚴腹贴法诱导肝纤维化兔模型。肝纤维化鼠模型在20W时,肝纤维化兔模型在8W、10W、12W分别行MDCT和MRI检查。以HE染色、Masson三色染色、透射电镜观察两种肝纤维模型肝脏病变,并对其纤维化程度和炎症进行分级分期。
结果肝纤维化兔模型4W时仅肝脏观察到炎性浸润,6W时出现急性虫卵结节,8W时观察到肝纤维化胶原沉积,10W及12W胶原沉积明显加重。病理学证实两种肝纤维化模型成功建立,两种模型纤维化程度相似,但是炎症评分肝纤维化鼠明显高于肝纤维化兔,具有统计学意义。肝纤维化鼠镜下脂肪变较肝纤维化兔明显。MDCT和MRI扫描可以显示两种肝纤维化模型肝体积缩小、腹水等间接征象。MDCT后处理重建计算肝脏体积,两种模型组体积小于对照组,并具有统计学差异。肝纤维化兔模型MRI扫描多次观察发现门脉分支扩张、门脉压力增高表现,并随时间而进展加重。
结论结合两种肝纤维化模型,有助于了解复杂的人类自然病程。MDCT和MRI扫描可以观察到肝纤维化模型肝体积缩小、腹水、门脉压力增高等间接表现,但无法提供定量评价指标。
第二部分两种肝纤维化动物模型DTI定量研究
目的两种肝纤维模型行DTI扫描并与病理分级行相关分析,初步探讨了DTI在肝纤维化定量研究的可行性及应用价值。
方法CC14诱导肝纤维化SD大鼠模型10只,同期对照5只及血吸虫腹贴法诱导新西兰大白兔肝纤维化模型18只,同期对照10只。肝纤维化鼠模型在造模后20W及断头处死后4h内离体肝组织,肝纤维化兔模型在造模后8W、10W、12W分别行DTI扫描(EPI, TR/TE=1600/68.1,6个方向,b=500s／mm2),完成扫描后以HE染色、Masson三色染色、透射电镜观察两种肝纤维模型肝脏病变,并对其纤维化程度和炎症进行分级分期。扫描图像经AW4.2工作站处理,计算并分析肝纤维化鼠模型和对照的在体和离体ADC值和各向异性值(FA),肝纤维化兔模型各个时期的ADC值和各向异性值(FA),并与病理分级行相关性分析,采用SSPS13.0进行统计分析,显著水平取0.05。
结果病理学证实两种肝纤维化模型均发生肝纤维化改变,两种模型纤维化程度分布相似,但是炎症评分肝纤维化鼠明显高于肝纤维化兔,具有统计学意义,肝纤维化鼠镜下脂肪变较肝纤维化兔明显。两种肝纤维化模型中ADC值和FA值改变一致,均表现为ADC值较对照组降低,FA值较对照组升高。具有统计学意义指标为肝纤维化鼠在体ADC值,肝纤维化兔ADC值。肝纤维化兔模型ADC值随着模型时间进展而减低,并且不同病理分级之间差别具有统计学意义。两种肝纤维化模型ADC值与肝纤维化分级之间存着负相关,并具有统计学意义。(肝纤维化鼠在体ADCr=-0.607P=0.016；肝纤维化兔,r=-0.765 P=<0.01)
结论两种肝纤维化模型病理分期与ADC值均有相关性,ADC值可成为定量评价肝纤维化指标。
第三部分两种肝纤维化动物模型1H-MRS定量研究
目的两种肝纤维模型行1H-MRS扫描并与病理分级行相关分析,初步探讨了1H-MRS在肝纤维化定量研究的可行性及应用价值。
方法CC14诱导肝纤维化SD大鼠模型10只,同期对照5只及血吸虫腹贴法诱导新西兰大白兔肝纤维化模型18只,同期对照10只。肝纤维化鼠模型在造模后20W,肝纤维化兔模型在造模后8W、10W、12W分别行1H-MRS扫描(PRESS, TR/TE=1500/35, FOV=16×16cm, NEX8,不抑水,时间2分12秒),完成扫描后以HE染色、Masson三色染色、透射电镜观察两种肝纤维模型肝脏病变,并对其纤维化程度和炎症进行分级分期。扫描图像经sage后处理,分别测量两种肝纤维化模型糖原和葡萄糖复合物(Glyu)、胆碱(Cho)、谷氨酰胺和谷氨酸复合物(Glx)、甘油三酯及其化合物(Lip)、水(Water)的平均峰高,并计算Fat%百分比[FAT=Lip/(lip+water)×100%],并与病理分级行相关性分析,采用SSPS13.0进行统计分析,显著水平取0.05。
结果病理学证实两种肝纤维化模型均发生肝纤维化改变,两种模型纤维化程度分布相似,但是炎症评分肝纤维化鼠明显高于肝纤维化兔,具有统计学意义,一肝纤维化鼠镜下脂肪变较肝纤维化兔明显。两种肝纤维化模型MRS均可以观察到Cho峰随着纤维化分期升高表现,Cho峰高在两种模型中均有统计学差异,并与肝纤维化分级呈正相关(肝纤维化鼠r=0.642,P<0.01；肝纤维化兔,r=0.643,P<0.01)。肝纤维化鼠模型Fat高于肝纤维化兔。
结论两种肝纤维化模型病理分期与Cho峰高均有相关性,Cho峰可成为定量评价肝纤维化指标。
第四部分两种肝纤维化动物模型T2*MAP定量研究
目的两种肝纤维模型行T2*Map扫描并火焰原子光谱法测定肝铁含量相对照,并与病理分级行相关分析,初步探讨了T2*Map在肝纤维化定量研究的可行性及应用价值。
方法CC14诱导肝纤维化SD大鼠模型10只,同期对照5只及血吸虫腹贴法诱导新西兰大白兔肝纤维化模型18只,同期对照10只。肝纤维化鼠模型在造模后20W,肝纤维化兔模型在造模后8W、10W、12W分别行T2*Map扫描(GRE,TR=100,FA=40,FOV=10×10cm,矩阵160×128,NEX6),完成扫描后以HE染色、Masson三色染色、透射电镜观察两种肝纤维模型肝脏病变,并对其纤维化程度和炎症进行分级分期。扫描图像经AW4.2工作站后处理,分别测量两种肝纤维化R2*值并与火焰原子光谱法测定肝铁含量相对照,并与病理分级行相关性分析,采用SSPS13.0进行统计分析,显著水平取0.05。
结果病理学证实两种肝纤维化模型均发生肝纤维化改变,两种模型纤维化程度分布相似,但是炎症评分肝纤维化鼠明显高于肝纤维化兔,具有统计学意义,肝纤维化鼠镜下脂肪变较肝纤维化兔明显。采用Spearman's法对肝铁铁含量和R2*值行相关性分析,两者呈明显正相关,r=0.966,P<0.01,肝纤维化鼠模型肝铁含量明显高于肝纤维化兔模型,而两者的对照组差别不大。两种肝纤维化模型R2*值较对照升高,并具有统计学意义。肝纤维化兔R2*值随模型进展时间升高,并与肝纤维化分级呈正相关(r=0.807,P<0.01)。
结论两种肝纤维化模型R2*值较对照升高,R2*值可成为定量评价肝纤维化模型铁沉积指标。肝纤维化鼠模型肝铁含量较肝纤维化兔模型高,可能与其炎症和脂肪变程度较重相关。
第五部分T2*MAP定量研究的临床初步应用
目的利用T2*Map扫描研究肝铁含量并与火焰原子光谱法测定肝铁含量相对照,初步探讨了T2*Map对肝铁含量进行定量研究的可行性及应用价值。
方法肝内占位26例患者术前三天内行T2*Map扫描(FGRE, TR=100, FA=40,FOV=40×40cm,层厚7mm,层间距lmm,矩阵160×128,NEX2)。扫描图像经AW4.2工作站后处理,分别测量肝内肿瘤及肿瘤旁肝组织R2*值并与火焰原子光谱法测定肿瘤旁肝组织铁含量相对照。采用SSPS13.0进行统计分析,显著水平取0.05。
结果术后病检证实原发性肝癌23例(中低分化11例,中分化8例,中高分化4例),血管瘤1例,局灶性结节增生2例。采用Spearman法对组织铁含量和R2*值行相关性分析,两者呈正相关(r=0.567,P=0.003)。肝癌患者癌旁肝组织的肝铁含量明显高于良性病变患者,但无统计学意义。肝癌组织的R2*低于癌旁组织,具有统计学意义。原发性肝癌病理分级之间的R2*值的差异,无统计学意义。
结论R2*值可成为定量评价肝铁沉积指标。肝癌组织的R2*值低于癌旁组织,可作为鉴别肝内占位的量化指标之一。
Part 1 The construction of experimental animal models with liver fibrosis
Purpose To construct a stable, reliable, and consistently animal models with liver fibrosis; to study liver lesions on MRI and CT, and to prepare for the further quantitative analysis and assessment for the functional MRI study.
Methods Fifty male Sprague-Dawley rats and thirty male New Zealand rabbits were used in this study,which were randomly assigned to the experimental group (rabbits n=20;rats n=40) and the control group (rabbits n=10;rats n=10). To duplicate model of liver fibrosis, the rats were intraperitoneal injected with CCL4,and the rabbits were transcutaneously infected with schistosomiasis cercariae. The rats were performed with MRI and MDCT after 20 weeks time, and the rabbits were performed with MRI and MDCT in the 8th,10th and 12th week. The observation on liver lesion was conducted by HE staining, Masson trichrome staining, transmission electron microscopy, and meanwhile the degree of fibrosis and inflammation was pathologically graded.
Results Only inflammatory infiltration were observed in the 4th week in the rabbits infected with schistosomiasis cercariae.The acute foreign granuloma node formed by worm eggs were observed in the 6th week,and then collagen deposition were observed in the 8th week. After that, the degree of collagen deposition was increased on the 10th and 12th week.All the experimental models were successfully duplicated with liver fibrosis,the score of liver fibrosis were similar in two kinds of models,but the score of inflammation between two kinds of models showed statistically significant difference,and the rats gain higher score than the rabbit did.MDCT and MR imaging showed indirect signs,such as liver size shrunk,and ascites. The liver volume were calculated with post-processed method on MDCT,and the volume of model groups were statistically significantly lower than that in the control groups.And the multiple observation on MRI showed that the branch of portal venous were extended,and the degree were aggravated over times.
Conclusion These two kinds of experimental animal models with liver fibrosis can help to understand the complex condition of human natural evolution. MDCT and MRI imaging can show the indirect sign of liver size reduction and ascites.
Part 2 Quantitative study of DTI in experimental animal models with liver fibrosis
Purpose Two kinds of experimental animal models were performed with DTI,and the results were correlated with the pathology results,to explore the feasibility and value of DTI in quantitative study of liver fibrosis.
Methods Two kinds of experimental animal models of liver fibrosis (10 rats were intraperitoneal injected with CCL4 and 18 New Zealand rabbits were transcutaneously infected with schistosomiasis cercariae) and the control ones (5 rats and 10 rabbits) were used in this study. The rats were performed with DTI imaging 20 weeks later and in vitro,and the rabbits were performed with DTI imaging in the 8th,10th and 12th week (EPI, TR/TE=1600/68.1, b=500s/mm2).The observation on liver lesion was conducted by HE staining, Masson trichrome staining, transmission electron microscopy, and meanwhile the degree of fibrosis and inflammation was pathologically graded. The apparent diffusion coefficient (ADC) and the fractional anisotropy(FA)of liver were measured on rats(in vivo and in vitro) and rabbits (8th week,10th week,12th week),the results were correlated with the pathology results. Statistical analysis was using SPSS13.0, take significant level of 0.05.
Results Pathology results confirmed two kinds of experimental animal models were successfully estabished. There was no statistically significant difference between the two model groups for the degree of liver fibrosis.And degree of the inflammation in the rat model group was statistically significant difference were higher than that in the rabbit model group.Meanwhile, steatosis of liver was widely distributed in the rat model group.The change of ADC values and FA value in the two model groups was similar, compared with the controls, the ADC values was decrease and FA value was increase.The ADC values of rats (in vivo)and ADC values of rabbits were both had statistically significant different from the control groups.The ADC values of rabbit model group were decrease as time pass by,and the ADC values between different pathological grading were statistically significant difference.There was significantly negative correlation between ADC values and pathological grading of fibrosis(in vivo ADC of rats r=-0.607 P=0.016; rabbits r=-0.765 P=<0.01).
Conclusion There was significantly negative correlation between ADC values and pathological grading of fibrosis in the two kinds of experimental animal models with liver fibrosis.ADC values can be quantitative evaluated with liver fibrosis.
Part 3 Quantitative study of'H-MRS in experimental animal models with liver fibrosis
Purpose Two kinds of experimental animal models were performed with 1H-MRS,and the results were correlated with the pathology results.To explore the feasibility and value of 'H-MRS in quantitative study of liver fibrosis.
Methods Two kinds of experimental animal models of liver fibrosis (10 rats were intraperitoneal injected with CCL4 and 18 New Zealand rabbits were transcutaneously infected with schistosomiasis cercariae) and the control ones(5 rats and 10 rabbits) were used in this study. The rats were performed with 1H-MRS imaging after 20 weeks,and the rabbits were performed with 1H-MRS in the 8th,10th and 12th week (PRESS, TR/TE= 1500/35, NEX8, none water suppress).The observation on liver lesion was conducted by HE staining, Masson trichrome staining, transmission electron microscopy, and meanwhile the degree of fibrosis and inflammation was pathologically graded. The 1H-MRS analysis was performed on workstation, and the results were correalted with the pathology results. Statistical analysis were using SPSS 13.0, take significant level of 0.05
Results Pathology results confirmed two kinds of experimental animal models were successfully estabished. There was no statistically significant difference between the two model groups for the degree of liver fibrosis.And degree of the inflammation in the rat model group was statistically significant difference were higher than that in the rabbit model group.Meanwhile, steatosis of liver was widely distributed in the rat model group. A significant statistical difference was observed between the control group vs.the liver fibrosis groups in choline (Cho). There is significantly positive correlation between Cho and pathological grading of fibrosis(rats r=0.642, P<0.01; rabbits r=0.643, P<0.01)
Conclusion There was significantly positive correlation between Cho and pathological grading of fibrosis in the two kinds of experimental animal models with liver fibrosis.Cho can be quantitative evaluated with liver fibrosis.
Part 4 Quantitative study of T2*map in experimental animal models with liver fibrosis Purpose Two kinds of experimental animal models were performed with T2*Map, and the results were correlated with the pathology results.To explore the feasibility and value of T2*Map in quantitative study of liver fibrosis.
Methods Two kinds of experimental animal models of liver fibrosis (10 rats were intraperitoneal injected with CCL4 and 18 New Zealand rabbits were transcutaneously infected with schistosomiasis cercariae) and the control ones (5 rats and 10 rabbits) were used in this study. The rats were performed with T2*Map after 20 weeks,and the rabbits were performed with T2*Map in the 8th,10th and 12th week (GRE, TR=100, FA=40, NEX 6). The observation on liver lesion was conducted by HE staining, Masson trichrome staining, transmission electron microscopy, and meanwhile the degree of fibrosis and inflammation was pathologically graded.The R2* value were measured on workstation, and the results were correalted with the pathology results. Statistical analysis were using SPSS13.0, taken significant level of 0.05
Results Pathology results confirmed two kinds of experimental animal models were successfully estabished. There was no statistically significant difference between the two model groups for the degree of liver fibrosis.And degree of the inflammation in the rat model group was statistically significant difference were higher than that in the rabbit model group.Meanwhile, steatosis of liver was widely distributed in the rat model group. There is significantly positive correlation between R2* values and liver iron content (r=0.966, P<0.01).And the liver iron content in liver fibrosis rats was higher than that in liver fibrosis rabbits. The R2* values of liver fibrosis rabbit were increase as time pass by. There was significantly positive correlation between R2* values of liver fibrosis rabbits and pathological grading of fibrosis(r=0.807, P<0.01)
Conclusion There was significantly positive correlation between R2* values and pathological grading of fibrosis. R2* values can be quantitative evaluated with liver fibrosis.
Part 5 Quantitative study of T2*map in Clinical application:Preliminary studies
Purpose To explore the feasibility and value of T2*Map in quantitative study of liver iron content in a clinic study.
Methods Twenty-six patients with focal liver lesion were performed with T2*Map (FGRE, TR=100, FA=40, NEX 2). The R2* value of liver lesion and liver tissue around the lesion were measured on workstation, and the results were correalted with the pathology results. Statistical analysis was using SPSS13.0, take significant level of 0.05.
Results All the patients were verified by postoperative pathological examination,there were 23 cases of primary liver carcinoma(11 were poorly-differentiated,8 were intermediately-differentiated and 4 were well-differentiated),1 case of hemangioma and 2 cases of focal nodular hyperplasia (FNH).There is significantly positive correlation between R2* values and liver iron content (r=0.567,P=0.003). R2* values of liver in patiens with malignant tumor were higher than the one with benign tumor, whereas no significant statistical difference was observed. A significant statistical difference was observed between liver tissue vs. liver tumor in R2* values.There is no significant statistical difference among different pathological grading of liver tumor.
Conclusion R2* values can be quantitative evaluated with liver iron content.The R2* values were lower in liver tumor than the normal liver,which can be used as a feature to identify liver lesion.
目的构建稳定、可靠、肝纤维化实验动物模型,研究模型肝脏病变的进展情况和常规影像学表现,为影像学功能成像定量评价做准备。
方法50只雄性清洁级Sprague-Dawley鼠,30只普通级雄性新西兰大白兔,随机分为实验组(新西兰大白兔n=20；SD大鼠n=40)和对照组(新西兰大白兔n=10;SD大鼠n=10)。采用CCL4(四氯化碳)腹腔注射法诱导肝纤维化鼠模型,血吸虫尾蚴腹贴法诱导肝纤维化兔模型。肝纤维化鼠模型在20W时,肝纤维化兔模型在8W、10W、12W分别行MDCT和MRI检查。以HE染色、Masson三色染色、透射电镜观察两种肝纤维模型肝脏病变,并对其纤维化程度和炎症进行分级分期。
结果肝纤维化兔模型4W时仅肝脏观察到炎性浸润,6W时出现急性虫卵结节,8W时观察到肝纤维化胶原沉积,10W及12W胶原沉积明显加重。病理学证实两种肝纤维化模型成功建立,两种模型纤维化程度相似,但是炎症评分肝纤维化鼠明显高于肝纤维化兔,具有统计学意义。肝纤维化鼠镜下脂肪变较肝纤维化兔明显。MDCT和MRI扫描可以显示两种肝纤维化模型肝体积缩小、腹水等间接征象。MDCT后处理重建计算肝脏体积,两种模型组体积小于对照组,并具有统计学差异。肝纤维化兔模型MRI扫描多次观察发现门脉分支扩张、门脉压力增高表现,并随时间而进展加重。
结论结合两种肝纤维化模型,有助于了解复杂的人类自然病程。MDCT和MRI扫描可以观察到肝纤维化模型肝体积缩小、腹水、门脉压力增高等间接表现,但无法提供定量评价指标。
第二部分两种肝纤维化动物模型DTI定量研究
目的两种肝纤维模型行DTI扫描并与病理分级行相关分析,初步探讨了DTI在肝纤维化定量研究的可行性及应用价值。
方法CC14诱导肝纤维化SD大鼠模型10只,同期对照5只及血吸虫腹贴法诱导新西兰大白兔肝纤维化模型18只,同期对照10只。肝纤维化鼠模型在造模后20W及断头处死后4h内离体肝组织,肝纤维化兔模型在造模后8W、10W、12W分别行DTI扫描(EPI, TR/TE=1600/68.1,6个方向,b=500s／mm2),完成扫描后以HE染色、Masson三色染色、透射电镜观察两种肝纤维模型肝脏病变,并对其纤维化程度和炎症进行分级分期。扫描图像经AW4.2工作站处理,计算并分析肝纤维化鼠模型和对照的在体和离体ADC值和各向异性值(FA),肝纤维化兔模型各个时期的ADC值和各向异性值(FA),并与病理分级行相关性分析,采用SSPS13.0进行统计分析,显著水平取0.05。
结果病理学证实两种肝纤维化模型均发生肝纤维化改变,两种模型纤维化程度分布相似,但是炎症评分肝纤维化鼠明显高于肝纤维化兔,具有统计学意义,肝纤维化鼠镜下脂肪变较肝纤维化兔明显。两种肝纤维化模型中ADC值和FA值改变一致,均表现为ADC值较对照组降低,FA值较对照组升高。具有统计学意义指标为肝纤维化鼠在体ADC值,肝纤维化兔ADC值。肝纤维化兔模型ADC值随着模型时间进展而减低,并且不同病理分级之间差别具有统计学意义。两种肝纤维化模型ADC值与肝纤维化分级之间存着负相关,并具有统计学意义。(肝纤维化鼠在体ADCr=-0.607P=0.016；肝纤维化兔,r=-0.765 P=<0.01)
结论两种肝纤维化模型病理分期与ADC值均有相关性,ADC值可成为定量评价肝纤维化指标。
第三部分两种肝纤维化动物模型1H-MRS定量研究
目的两种肝纤维模型行1H-MRS扫描并与病理分级行相关分析,初步探讨了1H-MRS在肝纤维化定量研究的可行性及应用价值。
方法CC14诱导肝纤维化SD大鼠模型10只,同期对照5只及血吸虫腹贴法诱导新西兰大白兔肝纤维化模型18只,同期对照10只。肝纤维化鼠模型在造模后20W,肝纤维化兔模型在造模后8W、10W、12W分别行1H-MRS扫描(PRESS, TR/TE=1500/35, FOV=16×16cm, NEX8,不抑水,时间2分12秒),完成扫描后以HE染色、Masson三色染色、透射电镜观察两种肝纤维模型肝脏病变,并对其纤维化程度和炎症进行分级分期。扫描图像经sage后处理,分别测量两种肝纤维化模型糖原和葡萄糖复合物(Glyu)、胆碱(Cho)、谷氨酰胺和谷氨酸复合物(Glx)、甘油三酯及其化合物(Lip)、水(Water)的平均峰高,并计算Fat%百分比[FAT=Lip/(lip+water)×100%],并与病理分级行相关性分析,采用SSPS13.0进行统计分析,显著水平取0.05。
结果病理学证实两种肝纤维化模型均发生肝纤维化改变,两种模型纤维化程度分布相似,但是炎症评分肝纤维化鼠明显高于肝纤维化兔,具有统计学意义,一肝纤维化鼠镜下脂肪变较肝纤维化兔明显。两种肝纤维化模型MRS均可以观察到Cho峰随着纤维化分期升高表现,Cho峰高在两种模型中均有统计学差异,并与肝纤维化分级呈正相关(肝纤维化鼠r=0.642,P<0.01；肝纤维化兔,r=0.643,P<0.01)。肝纤维化鼠模型Fat高于肝纤维化兔。
结论两种肝纤维化模型病理分期与Cho峰高均有相关性,Cho峰可成为定量评价肝纤维化指标。
第四部分两种肝纤维化动物模型T2*MAP定量研究
目的两种肝纤维模型行T2*Map扫描并火焰原子光谱法测定肝铁含量相对照,并与病理分级行相关分析,初步探讨了T2*Map在肝纤维化定量研究的可行性及应用价值。
方法CC14诱导肝纤维化SD大鼠模型10只,同期对照5只及血吸虫腹贴法诱导新西兰大白兔肝纤维化模型18只,同期对照10只。肝纤维化鼠模型在造模后20W,肝纤维化兔模型在造模后8W、10W、12W分别行T2*Map扫描(GRE,TR=100,FA=40,FOV=10×10cm,矩阵160×128,NEX6),完成扫描后以HE染色、Masson三色染色、透射电镜观察两种肝纤维模型肝脏病变,并对其纤维化程度和炎症进行分级分期。扫描图像经AW4.2工作站后处理,分别测量两种肝纤维化R2*值并与火焰原子光谱法测定肝铁含量相对照,并与病理分级行相关性分析,采用SSPS13.0进行统计分析,显著水平取0.05。
结果病理学证实两种肝纤维化模型均发生肝纤维化改变,两种模型纤维化程度分布相似,但是炎症评分肝纤维化鼠明显高于肝纤维化兔,具有统计学意义,肝纤维化鼠镜下脂肪变较肝纤维化兔明显。采用Spearman's法对肝铁铁含量和R2*值行相关性分析,两者呈明显正相关,r=0.966,P<0.01,肝纤维化鼠模型肝铁含量明显高于肝纤维化兔模型,而两者的对照组差别不大。两种肝纤维化模型R2*值较对照升高,并具有统计学意义。肝纤维化兔R2*值随模型进展时间升高,并与肝纤维化分级呈正相关(r=0.807,P<0.01)。
结论两种肝纤维化模型R2*值较对照升高,R2*值可成为定量评价肝纤维化模型铁沉积指标。肝纤维化鼠模型肝铁含量较肝纤维化兔模型高,可能与其炎症和脂肪变程度较重相关。
第五部分T2*MAP定量研究的临床初步应用
目的利用T2*Map扫描研究肝铁含量并与火焰原子光谱法测定肝铁含量相对照,初步探讨了T2*Map对肝铁含量进行定量研究的可行性及应用价值。
方法肝内占位26例患者术前三天内行T2*Map扫描(FGRE, TR=100, FA=40,FOV=40×40cm,层厚7mm,层间距lmm,矩阵160×128,NEX2)。扫描图像经AW4.2工作站后处理,分别测量肝内肿瘤及肿瘤旁肝组织R2*值并与火焰原子光谱法测定肿瘤旁肝组织铁含量相对照。采用SSPS13.0进行统计分析,显著水平取0.05。
结果术后病检证实原发性肝癌23例(中低分化11例,中分化8例,中高分化4例),血管瘤1例,局灶性结节增生2例。采用Spearman法对组织铁含量和R2*值行相关性分析,两者呈正相关(r=0.567,P=0.003)。肝癌患者癌旁肝组织的肝铁含量明显高于良性病变患者,但无统计学意义。肝癌组织的R2*低于癌旁组织,具有统计学意义。原发性肝癌病理分级之间的R2*值的差异,无统计学意义。
结论R2*值可成为定量评价肝铁沉积指标。肝癌组织的R2*值低于癌旁组织,可作为鉴别肝内占位的量化指标之一。
Part 1 The construction of experimental animal models with liver fibrosis
Purpose To construct a stable, reliable, and consistently animal models with liver fibrosis; to study liver lesions on MRI and CT, and to prepare for the further quantitative analysis and assessment for the functional MRI study.
Methods Fifty male Sprague-Dawley rats and thirty male New Zealand rabbits were used in this study,which were randomly assigned to the experimental group (rabbits n=20;rats n=40) and the control group (rabbits n=10;rats n=10). To duplicate model of liver fibrosis, the rats were intraperitoneal injected with CCL4,and the rabbits were transcutaneously infected with schistosomiasis cercariae. The rats were performed with MRI and MDCT after 20 weeks time, and the rabbits were performed with MRI and MDCT in the 8th,10th and 12th week. The observation on liver lesion was conducted by HE staining, Masson trichrome staining, transmission electron microscopy, and meanwhile the degree of fibrosis and inflammation was pathologically graded.
Results Only inflammatory infiltration were observed in the 4th week in the rabbits infected with schistosomiasis cercariae.The acute foreign granuloma node formed by worm eggs were observed in the 6th week,and then collagen deposition were observed in the 8th week. After that, the degree of collagen deposition was increased on the 10th and 12th week.All the experimental models were successfully duplicated with liver fibrosis,the score of liver fibrosis were similar in two kinds of models,but the score of inflammation between two kinds of models showed statistically significant difference,and the rats gain higher score than the rabbit did.MDCT and MR imaging showed indirect signs,such as liver size shrunk,and ascites. The liver volume were calculated with post-processed method on MDCT,and the volume of model groups were statistically significantly lower than that in the control groups.And the multiple observation on MRI showed that the branch of portal venous were extended,and the degree were aggravated over times.
Conclusion These two kinds of experimental animal models with liver fibrosis can help to understand the complex condition of human natural evolution. MDCT and MRI imaging can show the indirect sign of liver size reduction and ascites.
Part 2 Quantitative study of DTI in experimental animal models with liver fibrosis
Purpose Two kinds of experimental animal models were performed with DTI,and the results were correlated with the pathology results,to explore the feasibility and value of DTI in quantitative study of liver fibrosis.
Methods Two kinds of experimental animal models of liver fibrosis (10 rats were intraperitoneal injected with CCL4 and 18 New Zealand rabbits were transcutaneously infected with schistosomiasis cercariae) and the control ones (5 rats and 10 rabbits) were used in this study. The rats were performed with DTI imaging 20 weeks later and in vitro,and the rabbits were performed with DTI imaging in the 8th,10th and 12th week (EPI, TR/TE=1600/68.1, b=500s/mm2).The observation on liver lesion was conducted by HE staining, Masson trichrome staining, transmission electron microscopy, and meanwhile the degree of fibrosis and inflammation was pathologically graded. The apparent diffusion coefficient (ADC) and the fractional anisotropy(FA)of liver were measured on rats(in vivo and in vitro) and rabbits (8th week,10th week,12th week),the results were correlated with the pathology results. Statistical analysis was using SPSS13.0, take significant level of 0.05.
Results Pathology results confirmed two kinds of experimental animal models were successfully estabished. There was no statistically significant difference between the two model groups for the degree of liver fibrosis.And degree of the inflammation in the rat model group was statistically significant difference were higher than that in the rabbit model group.Meanwhile, steatosis of liver was widely distributed in the rat model group.The change of ADC values and FA value in the two model groups was similar, compared with the controls, the ADC values was decrease and FA value was increase.The ADC values of rats (in vivo)and ADC values of rabbits were both had statistically significant different from the control groups.The ADC values of rabbit model group were decrease as time pass by,and the ADC values between different pathological grading were statistically significant difference.There was significantly negative correlation between ADC values and pathological grading of fibrosis(in vivo ADC of rats r=-0.607 P=0.016; rabbits r=-0.765 P=<0.01).
Conclusion There was significantly negative correlation between ADC values and pathological grading of fibrosis in the two kinds of experimental animal models with liver fibrosis.ADC values can be quantitative evaluated with liver fibrosis.
Part 3 Quantitative study of'H-MRS in experimental animal models with liver fibrosis
Purpose Two kinds of experimental animal models were performed with 1H-MRS,and the results were correlated with the pathology results.To explore the feasibility and value of 'H-MRS in quantitative study of liver fibrosis.
Methods Two kinds of experimental animal models of liver fibrosis (10 rats were intraperitoneal injected with CCL4 and 18 New Zealand rabbits were transcutaneously infected with schistosomiasis cercariae) and the control ones(5 rats and 10 rabbits) were used in this study. The rats were performed with 1H-MRS imaging after 20 weeks,and the rabbits were performed with 1H-MRS in the 8th,10th and 12th week (PRESS, TR/TE= 1500/35, NEX8, none water suppress).The observation on liver lesion was conducted by HE staining, Masson trichrome staining, transmission electron microscopy, and meanwhile the degree of fibrosis and inflammation was pathologically graded. The 1H-MRS analysis was performed on workstation, and the results were correalted with the pathology results. Statistical analysis were using SPSS 13.0, take significant level of 0.05
Results Pathology results confirmed two kinds of experimental animal models were successfully estabished. There was no statistically significant difference between the two model groups for the degree of liver fibrosis.And degree of the inflammation in the rat model group was statistically significant difference were higher than that in the rabbit model group.Meanwhile, steatosis of liver was widely distributed in the rat model group. A significant statistical difference was observed between the control group vs.the liver fibrosis groups in choline (Cho). There is significantly positive correlation between Cho and pathological grading of fibrosis(rats r=0.642, P<0.01; rabbits r=0.643, P<0.01)
Conclusion There was significantly positive correlation between Cho and pathological grading of fibrosis in the two kinds of experimental animal models with liver fibrosis.Cho can be quantitative evaluated with liver fibrosis.
Part 4 Quantitative study of T2*map in experimental animal models with liver fibrosis Purpose Two kinds of experimental animal models were performed with T2*Map, and the results were correlated with the pathology results.To explore the feasibility and value of T2*Map in quantitative study of liver fibrosis.
Methods Two kinds of experimental animal models of liver fibrosis (10 rats were intraperitoneal injected with CCL4 and 18 New Zealand rabbits were transcutaneously infected with schistosomiasis cercariae) and the control ones (5 rats and 10 rabbits) were used in this study. The rats were performed with T2*Map after 20 weeks,and the rabbits were performed with T2*Map in the 8th,10th and 12th week (GRE, TR=100, FA=40, NEX 6). The observation on liver lesion was conducted by HE staining, Masson trichrome staining, transmission electron microscopy, and meanwhile the degree of fibrosis and inflammation was pathologically graded.The R2* value were measured on workstation, and the results were correalted with the pathology results. Statistical analysis were using SPSS13.0, taken significant level of 0.05
Results Pathology results confirmed two kinds of experimental animal models were successfully estabished. There was no statistically significant difference between the two model groups for the degree of liver fibrosis.And degree of the inflammation in the rat model group was statistically significant difference were higher than that in the rabbit model group.Meanwhile, steatosis of liver was widely distributed in the rat model group. There is significantly positive correlation between R2* values and liver iron content (r=0.966, P<0.01).And the liver iron content in liver fibrosis rats was higher than that in liver fibrosis rabbits. The R2* values of liver fibrosis rabbit were increase as time pass by. There was significantly positive correlation between R2* values of liver fibrosis rabbits and pathological grading of fibrosis(r=0.807, P<0.01)
Conclusion There was significantly positive correlation between R2* values and pathological grading of fibrosis. R2* values can be quantitative evaluated with liver fibrosis.
Part 5 Quantitative study of T2*map in Clinical application:Preliminary studies
Purpose To explore the feasibility and value of T2*Map in quantitative study of liver iron content in a clinic study.
Methods Twenty-six patients with focal liver lesion were performed with T2*Map (FGRE, TR=100, FA=40, NEX 2). The R2* value of liver lesion and liver tissue around the lesion were measured on workstation, and the results were correalted with the pathology results. Statistical analysis was using SPSS13.0, take significant level of 0.05.
Results All the patients were verified by postoperative pathological examination,there were 23 cases of primary liver carcinoma(11 were poorly-differentiated,8 were intermediately-differentiated and 4 were well-differentiated),1 case of hemangioma and 2 cases of focal nodular hyperplasia (FNH).There is significantly positive correlation between R2* values and liver iron content (r=0.567,P=0.003). R2* values of liver in patiens with malignant tumor were higher than the one with benign tumor, whereas no significant statistical difference was observed. A significant statistical difference was observed between liver tissue vs. liver tumor in R2* values.There is no significant statistical difference among different pathological grading of liver tumor.
Conclusion R2* values can be quantitative evaluated with liver iron content.The R2* values were lower in liver tumor than the normal liver,which can be used as a feature to identify liver lesion.
引文
[1]高春芳,陆伦根主编,纤维化疾病的基础和临床.In；上海科学技术出版社：上海,2004；p 592
[2]Okazaki I, Watanabe T, Hozawa S, et al. Molecular mechanism of the reversibility of hepatic fibrosis:with special reference to the role of matrix metalloproteinases.[J]. J Gastroenterol Hepatol,2000,15 Suppl:D26-D32.
[3]Okazaki I, Watanabe T, Hozawa S, et al. Reversibility of hepatic fibrosis:from the first report of collagenase in the liver to the possibility of gene therapy for recovery.[J]. Keio J Med,2001,50(2):58～65.
[4]McCrudden R, Iredale J P. Liver fibrosis, the hepatic stellate cell and tissue inhibitors of metalloproteinases.[J]. Histol Histopathol,2000,15(4):1159～1168.
[5]乔文福,康文喜,王健斌,等.病毒性肝炎患者两点肝穿刺活检诊断的比较[J].中华传染病杂志,1997,(02).
[6]张丽,胡道予,胡学梅,等.MRS和MR-DTI对肝硬化诊断、分级效果的比较[J].肝硬化是慢性肝病发展、恶化的一个中间环节,2009,(03)：459-461.
[7]黄聪武,白岚,蔡俊杰,等.血清铁和铁蛋白与肝病患者肝纤维化指标的关系[J].第一军医大学学报,2003,(05)：466-468.
[8]王超,杨镇,肖亮,等.乳果糖对门静脉高压鼠肠道屏障功能的影响[J].外科理论与实践,2010,(01).
[9]张爱龙,杨镇,肖亮,等.血吸虫病性门静脉高压症兔肝脏微血管构筑变化的研究[J].微循环学杂志,2007,(02).
[10]金琦,唐望先,周晟,等.肝炎平对家兔血吸虫肝纤维化MMP-2、TIMP-1表达的影响[J].华中科技大学学报(医学版),2005,(02).
[11]中华肝脏病学会肝纤维化学组.肝纤维化诊断及疗效评估共识[J].中华肝脏病杂志,2002,1Q(5)；327-328.
[12]胡晓峰,刘斌,刘可夫,等.家兔肝纤维化模型的建立及CT灌注成像[J].医学影像学杂志,2008,(01).
[13]曾燕,赵建农,冷志,等.不同浓度四氯化碳复合法诱导家兔肝纤维化模型的建立[J].第三军医大学学报,2009,(08).
[14]刘秀英,胡怡秀,胡余明,等.四氯化碳和猪血清肝纤维化模型组织病理比较[J].世界华人消化杂志,2004,(08).
[15]McLean E K, McLean A E, Sutton P M. Instant cirrhosis. An improved method for producing cirrhosis of the liver in rats by simultaneous administration of carbon tetrachloride and phenobarbitone.[J]. Br J Exp Pathol,1969,50(5):502～506.
[16]李校天,高红旗,蒋树林,等.四氯化碳和免疫血清法大鼠肝纤维化模型进程的时效关系对比研究[J].中国医师杂志,2003,(10)：1315-1317.
[17]蔡卫民,陈智,陈峰,等.日本血吸虫虫卵肉芽肿与肝纤维化免疫病理及调节研 究初步报告[J].中国血吸虫病防治杂志,1998,(S1).
[18]杨艳宏,蔡卫民,金国梁,等.日本血吸虫感染兔肝肌成纤维细胞的动态变化及其意义[J].中华医学杂志,1999,(11).
[19]黄晓丽,唐望先,但自力,等.日本血吸虫性病兔肝纤维化的酶组织化学研究[J].中国组织化学与细胞化学杂志,2005,(03).
[20]陈峰,蔡卫民,陈智,等.日本血吸虫病兔肝纤维化胶原合成与降解转录水平的研究[J].中国寄生虫学与寄生虫病杂志,2001,(02).
[21]蒋树林,姚希贤,郭林选.CC14和PS两种SD大鼠模型肝纤维化进程时效关系对比研究[J].中国实验动物学报,2003,(02).
[1]高春芳,陆伦根主编,纤维化疾病的基础和临床.In；上海科学技术出版社：上海,2004;p 592
[2]张爱龙,杨镇,肖亮,等.血吸虫病性门静脉高压症兔肝脏微血管构筑变化的研究[J].微循环学杂志,2007,(02).
[3]金琦,唐望先,周晟,等.肝炎平对家兔血吸虫肝纤维化MMP-2、TIMP-1表达的影响[J].华中科技大学学报(医学版),2005,(02).
[4]王超,杨镇,肖亮,等.乳果糖对门静脉高压鼠肠道屏障功能的影响[J].外科 理论与实践,2010,(01).
[5]中华肝脏病学会肝纤维化学组.肝纤维化诊断及疗效评估共识[J].中华肝脏病杂志,2002,10(5)：327-328.
[6]胡晓峰,刘斌,刘可夫,等.家兔肝纤维化模型的建立及CT灌注成像[J].医学影像学杂志,2008,(01).
[7]Sinha S, Bastin M E, Whittle IR, et al. Diffusion tensor MR imaging of high-grade cerebral gliomas.[J]. AJNR Am J Neuroradiol,2002,23(4):520～527.
[8]张丽,胡道予,胡学梅,等.MRS和MR-DTI对肝硬化诊断、分级效果的比较[J].中国医学影像技术,2009,(03)：459-461.
[9]管生,赵卫东,周康荣,等.磁共振功能弥散成像对肝脏早期弥漫性病变诊断价值的实验研究[J].中华肝脏病杂志,2005,(07).
[10]Ichikawa T, Haradome H, Hachiya J, et al. Diffusion-weighted MR imaging with a single-shot echoplanar sequence:detection and characterization of focal hepatic lesions.[J]. AJR Am J Roentgenol,1998,170(2):397～402.
[11]Taouli B, Vilgrain V, Dumont E, et al. Evaluation of liver diffusion isotropy and characterization of focal hepatic lesions with two single-shot echo-planar MR imaging sequences:prospective study in 66 patients.[J]. Radiology,2003,226(1): 71-78.
[12]杨正汉,谢敬霞,胡碧芳,等.肝硬化组织表观扩散系数改变及其可能机制的实验研究[J].中国医学影像技术,2002,(09).
[13]Koinuma M, Ohashi I, Hanafusa K, et al. Apparent diffusion coefficient measurements with diffusion-weighted magnetic resonance imaging for evaluation of hepatic fibrosis.[J]. J Magn Reson Imaging,2005,22(1):80～85.
[14]Aube C, Racineux P X, Lebigot J, et al. [Diagnosis and quantification of hepatic fibrosis with diffusion weighted MR imaging:preliminary results][J]. J Radiol,2004, 85(3):301-306.
[15]王秋实,郭启勇,梁长虹,等.MR弥散加权成像评价肝纤维化的初步实验研究[J].解剖学研究,2007,(03).
[1]张爱龙,杨镇,肖亮,等.血吸虫病性门静脉高压症兔肝脏微血管构筑变化的研究[J].微循环学杂志,2007,(02).
[2]金琦,唐望先,周晟,等.肝炎平对家兔血吸虫肝纤维化MMP-2、TIMP-1表达的影响[J].华中科技大学学报(医学版),2005,(02).
[3]王超,杨镇,肖亮,等.乳果糖对门静脉高压鼠肠道屏障功能的影响[J].外科 理论与实践,2010,(01).
[4]钟喨,陈洁,程杰军,等.脂肪肝的磁共振检测与对照分析[J].近年来,2008,(12).
[5]饶晶晶,曹四海,王南,等.氢质子磁共振波谱在非酒精性脂肪性肝病中的应用研究[J].临床放射学,2008,(10).
[6]中华肝脏病学会肝纤维化学组.肝纤维化诊断及疗效评估共识[J].中华肝脏病杂志,2002,10(5)：327-328.
[7]胡晓峰,刘斌,刘可夫,等.家兔肝纤维化模型的建立及CT灌注成像[J].医学影像学杂志,2008,(01).
[8]张丽,胡道予,胡学梅,等.MRS和MR-DTI对肝硬化诊断、分级效果的比较[J].中国医学影像技术,2009,(03)：459-461.
[9]王南,董慧,陆付耳,等.2型糖尿病大鼠肝脏甘油三酯含量的磁共振氢谱研究[J].放射学实践,2009,(08).
[10]Szczepaniak L S, Babcock E E, Schick F, et al. Measurement of intracellular triglyceride stores by H spectroscopy:validation in vivo.[J]. Am J Physiol,1999, 276(5 Pt 1):E977～E989.
[11]Vuppalanchi R, Cummings O W, Saxena R, et al. Relationship among histologic, radiologic, and biochemical assessments of hepatic steatosis:a study of human liver samples.[J]. J Clin Gastroenterol,2007,41(2):206～210.
[12]刘蒙,高鑫,饶圣祥,等.质子磁共振波谱分析定量检测肝脏脂肪含量方法的建立与临床应用[J].中华医学杂志,2008,88(8).
[13]Thomas E L, Hamilton G, Patel N, et al. Hepatic triglyceride content and its relation to body adiposity:a magnetic resonance imaging and proton magnetic resonance spectroscopy study.[J]. Gut,2005,54(1):122～127.
[14]Ricci P E, Pitt A, Keller P J, et al. Effect of voxel position on single-voxel MR spectroscopy findings.[J]. AJNR Am J Neuroradiol,2000,21(2):367～374.
[15]张静,程流泉,叶慧义,等.正常肝脏3.0T质子MRS的定量研究[J].中国医学影 像技术,2007,(08).
[16]张丽,胡道予,饶晶晶,等.正常人肝脏单体素1.5T 1H-MRS的研究[J].放射学实践,2007,22(4).
[17]Orlacchio A, Bolacchi F, Angelico M, et al. In vivo, high-field,3-Tesla 1H MR spectroscopic assessment of liver fibrosis in HCV-correlated chronic liver disease. [J]. Radiol Med,2008,113(2):289～299.
[18]唐玉德,王耿,刘树学,等.氢质子波谱在乙型肝炎相关慢性肝病的研究[J].中国医学影像技术,2009,(07).
[19]唐珉,李刚,宫京闽,等.感染血吸虫家兔肝脏组织化学的观察[J].中国人兽共患病杂志,2005,(01).
[1]黄聪武,白岚,蔡俊杰,等.血清铁和铁蛋白与肝病患者肝纤维化指标的关系[J].第一军医大学学报,2003,(05)：466-468.
[2]张爱龙,杨镇,肖亮,等.血吸虫病性门静脉高压症兔肝脏微血管构筑变化的研究[J].微循环学杂志,2007,(02).
[3]金琦,唐望先,周晟,等.肝炎平对家兔血吸虫肝纤维化MMP-2、TIMP-1表达的影响[J].华中科技大学学报(医学版),2005,(02).
[4]王超,杨镇,肖亮,等.乳果糖对门静脉高压鼠肠道屏障功能的影响[J].外科理论与实践,2010,(01).
[5]中华肝脏病学会肝纤维化学组.肝纤维化诊断及疗效评估共识[J].中华肝脏病杂志,2002,10(5)：327-328.
[6]胡晓峰,刘斌,刘可夫,等.家兔肝纤维化模型的建立及CT灌注成像[J].医学影像学杂志,2008,(01).
[7]于德新,李传福.肝铁过载及MRI无创评估研究进展[J].国际医学放射学杂志,2009,(02).
[8]冷慧敏,骆新民,朱航.小鼠铁过量模型建立及相关指标的观察研究[J].齐鲁医学杂志,2008,(04)：331-334.
[9]Cardin R, D'Errico A, Fiorentino M, et al. Hepatocyte proliferation and apoptosis in relation to oxidative damage in alcohol-related liver disease.[J]. Alcohol,2002, 37(1):43～48.
[10]曹治宸,白玉,杨学农,等.乙型肝炎肝损伤中铁代谢异常的研究[J].中华肝脏 病杂志,2001,(01).
[11]金延方,孙非,岳云龙,等.应用MRS和R2-*半定量法评价服用枫树油对MRI检查的影响[J].中国医学影像技术,2007,(03).
[12]吴冬青,林敏,安红钢,等.火焰原子吸收光谱法测定12种药用植物花中金属元素[J].光谱实验室,2009,(01).
[13]黄聪武,詹海勇,李国平,等.血清铁和血清铁蛋白与病毒性肝炎患者肝纤维化指标的关系[J].铁是人体必需的微量元素。人体内的含铁化合物主要为亚铁血红蛋白、铁蛋白和含铁血黄素,2007,(03).
[14]宋良文,王德文,崔雪梅,et al.铁、牛磺酸和精氨酸对大鼠肝纤维化的影响[J].中华放射医学与防护杂志,1997,17：410-413,R818,R575,R341,R977,R914.
[15]Ishida M, Nakagawara G, Imamura Y, et al. Iron and copper deposition in chronic active hepatitis and liver cirrhosis; pathogenetic role in progressive liver cell damage.[J]. Eur J Histochem,1995,39(3):221～236.
[16]Cable E E, Connor J R, Isom H C. Accumulation of iron by primary rat hepatocytes in long-term culture:changes in nuclear shape mediated by non-transferrin-bound forms of iron.[J]. Am J Pathol,1998,152(3):781～792.
[17]江远,张玲,何金洋,等.在二甲基亚硝胺诱导大鼠肝纤维化时铁超载和脂肪堆积的作用[J].中西医结合肝病,2009,(02).
[1]Tanimoto A, Oshio K, Suematsu M, et al. Relaxation effects of clustered particles. [J]. J Magn Reson Imaging,2001,14(1):72-77.
[2]Alexopoulou E, Stripeli F, Baras P, et al. R2 relaxometry with MRI for the quantification of tissue iron overload in beta-thalassemic patients.[J]. J Magn Reson Imaging,2006,23(2):163～170.
[3]金延方,孙非,岳云龙,等.应用MRS和R2-*半定量法评价服用枫树油对MRI检查的影响[J].中国医学影像技术,2007,(03).
[4]黄自力,黄文才,李国雄.菲力磁增强磁共振诊断急性放射性肝损伤的实验研究[J].华南国防医学杂志,2008,(05)：24-26.
[5]Siegers C P, Bumann D, Trepkau H D, et al. Influence of dietary iron overload on cell proliferation and intestinal tumorigenesis in mice.[J]. Cancer Lett,1992,65(3): 245～249.
[6]汤晴,朱天义.铁缺乏对鼠肝癌发生的抑制作用的研究[J].中国公共卫生,1999,(04).
[7]Rouach H, Fataccioli V, Gentil M, et al. Effect of chronic ethanol feeding on lipid peroxidation and protein oxidation in relation to liver pathology. [J]. Hepatology, 1997,25(2):351-355.
[8]黄聪武,白岚,蔡俊杰,等.血清铁和铁蛋白与肝病患者肝纤维化指标的关系[J].第一军医大学学报,2003,(05)：466-468.
[9]Pinelli A, Trivulzio S, Tomasoni L, et al. High-dose vitamin E lowers urine porphyrin levels in patients affected by porphyria cutanea tarda.[J]. Pharmacol Res, 2002,45(4):355～359.
[10]Bayraktar Y, Koseoglu T, Somner C, et al. The use of deferoxamine infusions to enhance the response rate to interferon-alpha treatment of chronic viral hepatitis B.[J]. J Viral Hepat,1996,3(3):129～135.
[1]高春芳,陆伦根主编,纤维化疾病的基础和临床.In；上海科学技术出版社：上海,2004;p 592
[2]Okazaki I, Watanabe T, Hozawa S, et al. Molecular mechanism of the reversibility of hepatic fibrosis:with special reference to the role of matrix metalloproteinases.[J]. J Gastroenterol Hepatol,2000,15 Suppl:D26～D32.
[3]Okazaki I, Watanabe T, Hozawa S, et al. Reversibility of hepatic fibrosis:from the first report of collagenase in the liver to the possibility of gene therapy for recovery.[J]. Keio J Med,2001,50(2):58-65.
[4]McCrudden R, Iredale J P. Liver fibrosis, the hepatic stellate cell and tissue inhibitors of metalloproteinases.[J]. Histol Histopathol,2000,15(4):1159～1168.
[5]管生,赵卫东,周康荣,等.原发性肝细胞癌癌前病变血液动力学的MR实验研究[J].中华放射学杂志,2006,(03).
[6]张铁宁,张皓,缪竞陶.MR灌注成像在肝脏常见占位性病变诊断及鉴别诊断中的价值初探[J].中国医学影像技术,2006,(12).
[7]Ichikawa T, Haradome H, Hachiya J, et al. Perfusion-weighted MR imaging in the upper abdomen:preliminary clinical experience in 61 patients.[J]. AJR Am J Roentgenol,1997,169(4):1061-1066.
[8]Fujita T, Ito K, Honjo K, et al. Hepatic parenchymal enhancement in the cirrhotic liver:evaluation by triple-phase dynamic MRI.[J]. Abdom Imaging,2002,27(1): 29～33.
[9]胡晓峰,刘斌,钱银锋,等.磁共振灌注成像对肝纤维化的实验性研究[J].放射学实践,2008,(10).
[10]张皓,顾爱华,缪竞陶,等.晚期肝硬化肝脏MR灌注成像的灌注量化分析[J].放射学实践,2006,(12).
[11]管生,赵卫东,周康荣,等.磁共振功能弥散成像对肝脏早期弥漫性病变诊断价值的实验研究[J].中华肝脏病杂志,2005,(07).
[12]Taouli B, Vilgrain V, Dumont E, et al. Evaluation of liver diffusion isotropy and characterization of focal hepatic lesions with two single-shot echo-planar MR imaging sequences:prospective study in 66 patients.[J]. Radiology,2003,226(1): 71～78.
[13]张丽,胡道予,胡学梅,等.MRS和MR-DTI对肝硬化诊断、分级效果的比较[J].中国医学影像技术,2009,(03)：459-461.
[14]Koinuma M, Ohashi I, Hanafusa K, et al. Apparent diffusion coefficient measurements with diffusion-weighted magnetic resonance imaging for evaluation of hepatic fibrosis.[J]. J Magn Reson Imaging,2005,22(1):80～85.
[15]Aube C, Racineux P X, Lebigot J, et al. [Diagnosis and quantification of hepatic fibrosis with diffusion weighted MR imaging:preliminary results][J]. J Radiol,2004, 85(3):301～306.
[16]王秋实,郭启勇,梁长虹,等.MR弥散加权成像评价肝纤维化的初步实验研究[J].解剖学研究,2007,(03).
[17]杨正汉,谢敬霞,胡碧芳,等.肝硬化组织表观扩散系数改变及其可能机制的实验研究[J].中国医学影像技术,2002,(09).
[18]王宏伟.磁化传递成像技术与神经系统疾病[J].国外医学临床放射学分册,2002,(03)：144-148.
[19]Chen J H, Chai J W, Shen W C. Magnetization transfer contrast imaging of liver cirrhosis.[J]. Hepatogastroenterology,1999,46(29):2872～2877.
[20]Hollett M D, Aisen A M, Yeung H N, et al. Magnetization transfer contrast imaging of hepatic neoplasms.[J]. Magn Reson Imaging,1994,12(1):1～8.
[21]马国林,沈文,张学滨,等.肝纤维化和肝硬化磁化传递成像与血清学指标相关性研究[J].实用放射学杂志,2009,
[22]Bieri O, Maderwald S, Ladd M E, et al. Balanced alternating steady-state elastography.[J]. Magn Reson Med,2006,55(2):233～241.
[23]Suga M, Matsuda T, Minato K, et al. Measurement of in vivo local shear modulus
using MR elastography multiple-phase patchwork offsets. [J]. IEEE Trans Biomed Eng,2003,50(7):908-915.
[24]Manduca A, Oliphant T E, Dresner M A, et al. Magnetic resonance elastography: non-invasive mapping of tissue elasticity.[J]. Med Image Anal,2001,5(4):237～ 254.
[25]Rouviere O, Yin M, Dresner M A, et al. MR elastography of the liver:preliminary results.[J]. Radiology,2006,240(2):440-448.
[26]Huwart L, Peeters F, Sinkus R, et al. Liver fibrosis:non-invasive assessment with MR elastography.[J]. NMR Biomed,2006,19(2):173-179.
[27]田艳,范竹萍,顾海燕.磁共振技术对脂肪性肝病诊断的进展[J].世界华人消化杂志,2007,(24).
[28]Orlacchio A, Bolacchi F, Angelico M, et al. In vivo, high-field,3-Tesla 1H MR spectroscopic assessment of liver fibrosis in HCV-correlated chronic liver disease.[J]. Radiol Med,2008,113(2):289～299.
[29]Cho, Gu S, Kim M Y, et al. Chronic Hepatitis:In Vivo Proton MR Spectroscopic Evaluation of the Liver and Correlation with Histopathologic Findings[J]. Radiology, 2001,221(3):740～746.
[30]Noren B, Dahlqvist O, Lundberg P, et al. Separation of advanced from mild fibrosis in diffuse liver disease using 31P magnetic resonance spectroscopy.[J]. Eur J Radiol, 2008,66(2):313～320.
[31]于德新,马祥兴,李笃民,等.～(31)P-MRS在评估肝硬化及其分级中的价值[J].临床放射学杂志,2009,(07).
[32]Dezortova M, Taimr P, Skoch A, et al. Etiology and functional status of liver cirrhosis by 31P MR spectroscopy.[J]. World J Gastroenterol,2005,11(44):6926～ 6931.
[33]Menon D K, Harris M, Sargentoni J, et al. In vivo hepatic 31P magnetic resonance spectroscopy in chronic alcohol abusers.[J]. Gastroenterology,1995,108(3):776～ 788.
[34]黄聪武,白岚,蔡俊杰,等.血清铁和铁蛋白与肝病患者肝纤维化指标的关系[J].第一军医大学学报,2003,(05)：466-468.
[35]Alexopoulou E, Stripeli F, Baras P, et al. R2 relaxometry with MRI for the quantification of tissue iron overload in beta-thalassemic patients. [J]. J Magn Reson Imaging,2006,23(2):163～170.
[36]Tanimoto A, Oshio K, Suematsu M, et al. Relaxation effects of clustered particles.[J]. J Magn Reson Imaging,2001,14(1):72～77.
[37]Gandon Y, Olivie D, Guyader D, et al. Non-invasive assessment of hepatic iron stores by MRI.[J]. Lancet,2004,363(9406):357～362.
[2]Okazaki I, Watanabe T, Hozawa S, et al. Molecular mechanism of the reversibility of hepatic fibrosis:with special reference to the role of matrix metalloproteinases.[J]. J Gastroenterol Hepatol,2000,15 Suppl:D26-D32.
[3]Okazaki I, Watanabe T, Hozawa S, et al. Reversibility of hepatic fibrosis:from the first report of collagenase in the liver to the possibility of gene therapy for recovery.[J]. Keio J Med,2001,50(2):58～65.
[4]McCrudden R, Iredale J P. Liver fibrosis, the hepatic stellate cell and tissue inhibitors of metalloproteinases.[J]. Histol Histopathol,2000,15(4):1159～1168.
[5]乔文福,康文喜,王健斌,等.病毒性肝炎患者两点肝穿刺活检诊断的比较[J].中华传染病杂志,1997,(02).
[6]张丽,胡道予,胡学梅,等.MRS和MR-DTI对肝硬化诊断、分级效果的比较[J].肝硬化是慢性肝病发展、恶化的一个中间环节,2009,(03)：459-461.
[7]黄聪武,白岚,蔡俊杰,等.血清铁和铁蛋白与肝病患者肝纤维化指标的关系[J].第一军医大学学报,2003,(05)：466-468.
[8]王超,杨镇,肖亮,等.乳果糖对门静脉高压鼠肠道屏障功能的影响[J].外科理论与实践,2010,(01).
[9]张爱龙,杨镇,肖亮,等.血吸虫病性门静脉高压症兔肝脏微血管构筑变化的研究[J].微循环学杂志,2007,(02).
[10]金琦,唐望先,周晟,等.肝炎平对家兔血吸虫肝纤维化MMP-2、TIMP-1表达的影响[J].华中科技大学学报(医学版),2005,(02).
[11]中华肝脏病学会肝纤维化学组.肝纤维化诊断及疗效评估共识[J].中华肝脏病杂志,2002,1Q(5)；327-328.
[12]胡晓峰,刘斌,刘可夫,等.家兔肝纤维化模型的建立及CT灌注成像[J].医学影像学杂志,2008,(01).
[13]曾燕,赵建农,冷志,等.不同浓度四氯化碳复合法诱导家兔肝纤维化模型的建立[J].第三军医大学学报,2009,(08).
[14]刘秀英,胡怡秀,胡余明,等.四氯化碳和猪血清肝纤维化模型组织病理比较[J].世界华人消化杂志,2004,(08).
[15]McLean E K, McLean A E, Sutton P M. Instant cirrhosis. An improved method for producing cirrhosis of the liver in rats by simultaneous administration of carbon tetrachloride and phenobarbitone.[J]. Br J Exp Pathol,1969,50(5):502～506.
[16]李校天,高红旗,蒋树林,等.四氯化碳和免疫血清法大鼠肝纤维化模型进程的时效关系对比研究[J].中国医师杂志,2003,(10)：1315-1317.
[17]蔡卫民,陈智,陈峰,等.日本血吸虫虫卵肉芽肿与肝纤维化免疫病理及调节研 究初步报告[J].中国血吸虫病防治杂志,1998,(S1).
[18]杨艳宏,蔡卫民,金国梁,等.日本血吸虫感染兔肝肌成纤维细胞的动态变化及其意义[J].中华医学杂志,1999,(11).
[19]黄晓丽,唐望先,但自力,等.日本血吸虫性病兔肝纤维化的酶组织化学研究[J].中国组织化学与细胞化学杂志,2005,(03).
[20]陈峰,蔡卫民,陈智,等.日本血吸虫病兔肝纤维化胶原合成与降解转录水平的研究[J].中国寄生虫学与寄生虫病杂志,2001,(02).
[21]蒋树林,姚希贤,郭林选.CC14和PS两种SD大鼠模型肝纤维化进程时效关系对比研究[J].中国实验动物学报,2003,(02).
[1]高春芳,陆伦根主编,纤维化疾病的基础和临床.In；上海科学技术出版社：上海,2004;p 592
[2]张爱龙,杨镇,肖亮,等.血吸虫病性门静脉高压症兔肝脏微血管构筑变化的研究[J].微循环学杂志,2007,(02).
[3]金琦,唐望先,周晟,等.肝炎平对家兔血吸虫肝纤维化MMP-2、TIMP-1表达的影响[J].华中科技大学学报(医学版),2005,(02).
[4]王超,杨镇,肖亮,等.乳果糖对门静脉高压鼠肠道屏障功能的影响[J].外科 理论与实践,2010,(01).
[5]中华肝脏病学会肝纤维化学组.肝纤维化诊断及疗效评估共识[J].中华肝脏病杂志,2002,10(5)：327-328.
[6]胡晓峰,刘斌,刘可夫,等.家兔肝纤维化模型的建立及CT灌注成像[J].医学影像学杂志,2008,(01).
[7]Sinha S, Bastin M E, Whittle IR, et al. Diffusion tensor MR imaging of high-grade cerebral gliomas.[J]. AJNR Am J Neuroradiol,2002,23(4):520～527.
[8]张丽,胡道予,胡学梅,等.MRS和MR-DTI对肝硬化诊断、分级效果的比较[J].中国医学影像技术,2009,(03)：459-461.
[9]管生,赵卫东,周康荣,等.磁共振功能弥散成像对肝脏早期弥漫性病变诊断价值的实验研究[J].中华肝脏病杂志,2005,(07).
[10]Ichikawa T, Haradome H, Hachiya J, et al. Diffusion-weighted MR imaging with a single-shot echoplanar sequence:detection and characterization of focal hepatic lesions.[J]. AJR Am J Roentgenol,1998,170(2):397～402.
[11]Taouli B, Vilgrain V, Dumont E, et al. Evaluation of liver diffusion isotropy and characterization of focal hepatic lesions with two single-shot echo-planar MR imaging sequences:prospective study in 66 patients.[J]. Radiology,2003,226(1): 71-78.
[12]杨正汉,谢敬霞,胡碧芳,等.肝硬化组织表观扩散系数改变及其可能机制的实验研究[J].中国医学影像技术,2002,(09).
[13]Koinuma M, Ohashi I, Hanafusa K, et al. Apparent diffusion coefficient measurements with diffusion-weighted magnetic resonance imaging for evaluation of hepatic fibrosis.[J]. J Magn Reson Imaging,2005,22(1):80～85.
[14]Aube C, Racineux P X, Lebigot J, et al. [Diagnosis and quantification of hepatic fibrosis with diffusion weighted MR imaging:preliminary results][J]. J Radiol,2004, 85(3):301-306.
[15]王秋实,郭启勇,梁长虹,等.MR弥散加权成像评价肝纤维化的初步实验研究[J].解剖学研究,2007,(03).
[1]张爱龙,杨镇,肖亮,等.血吸虫病性门静脉高压症兔肝脏微血管构筑变化的研究[J].微循环学杂志,2007,(02).
[2]金琦,唐望先,周晟,等.肝炎平对家兔血吸虫肝纤维化MMP-2、TIMP-1表达的影响[J].华中科技大学学报(医学版),2005,(02).
[3]王超,杨镇,肖亮,等.乳果糖对门静脉高压鼠肠道屏障功能的影响[J].外科 理论与实践,2010,(01).
[4]钟喨,陈洁,程杰军,等.脂肪肝的磁共振检测与对照分析[J].近年来,2008,(12).
[5]饶晶晶,曹四海,王南,等.氢质子磁共振波谱在非酒精性脂肪性肝病中的应用研究[J].临床放射学,2008,(10).
[6]中华肝脏病学会肝纤维化学组.肝纤维化诊断及疗效评估共识[J].中华肝脏病杂志,2002,10(5)：327-328.
[7]胡晓峰,刘斌,刘可夫,等.家兔肝纤维化模型的建立及CT灌注成像[J].医学影像学杂志,2008,(01).
[8]张丽,胡道予,胡学梅,等.MRS和MR-DTI对肝硬化诊断、分级效果的比较[J].中国医学影像技术,2009,(03)：459-461.
[9]王南,董慧,陆付耳,等.2型糖尿病大鼠肝脏甘油三酯含量的磁共振氢谱研究[J].放射学实践,2009,(08).
[10]Szczepaniak L S, Babcock E E, Schick F, et al. Measurement of intracellular triglyceride stores by H spectroscopy:validation in vivo.[J]. Am J Physiol,1999, 276(5 Pt 1):E977～E989.
[11]Vuppalanchi R, Cummings O W, Saxena R, et al. Relationship among histologic, radiologic, and biochemical assessments of hepatic steatosis:a study of human liver samples.[J]. J Clin Gastroenterol,2007,41(2):206～210.
[12]刘蒙,高鑫,饶圣祥,等.质子磁共振波谱分析定量检测肝脏脂肪含量方法的建立与临床应用[J].中华医学杂志,2008,88(8).
[13]Thomas E L, Hamilton G, Patel N, et al. Hepatic triglyceride content and its relation to body adiposity:a magnetic resonance imaging and proton magnetic resonance spectroscopy study.[J]. Gut,2005,54(1):122～127.
[14]Ricci P E, Pitt A, Keller P J, et al. Effect of voxel position on single-voxel MR spectroscopy findings.[J]. AJNR Am J Neuroradiol,2000,21(2):367～374.
[15]张静,程流泉,叶慧义,等.正常肝脏3.0T质子MRS的定量研究[J].中国医学影 像技术,2007,(08).
[16]张丽,胡道予,饶晶晶,等.正常人肝脏单体素1.5T 1H-MRS的研究[J].放射学实践,2007,22(4).
[17]Orlacchio A, Bolacchi F, Angelico M, et al. In vivo, high-field,3-Tesla 1H MR spectroscopic assessment of liver fibrosis in HCV-correlated chronic liver disease. [J]. Radiol Med,2008,113(2):289～299.
[18]唐玉德,王耿,刘树学,等.氢质子波谱在乙型肝炎相关慢性肝病的研究[J].中国医学影像技术,2009,(07).
[19]唐珉,李刚,宫京闽,等.感染血吸虫家兔肝脏组织化学的观察[J].中国人兽共患病杂志,2005,(01).
[1]黄聪武,白岚,蔡俊杰,等.血清铁和铁蛋白与肝病患者肝纤维化指标的关系[J].第一军医大学学报,2003,(05)：466-468.
[2]张爱龙,杨镇,肖亮,等.血吸虫病性门静脉高压症兔肝脏微血管构筑变化的研究[J].微循环学杂志,2007,(02).
[3]金琦,唐望先,周晟,等.肝炎平对家兔血吸虫肝纤维化MMP-2、TIMP-1表达的影响[J].华中科技大学学报(医学版),2005,(02).
[4]王超,杨镇,肖亮,等.乳果糖对门静脉高压鼠肠道屏障功能的影响[J].外科理论与实践,2010,(01).
[5]中华肝脏病学会肝纤维化学组.肝纤维化诊断及疗效评估共识[J].中华肝脏病杂志,2002,10(5)：327-328.
[6]胡晓峰,刘斌,刘可夫,等.家兔肝纤维化模型的建立及CT灌注成像[J].医学影像学杂志,2008,(01).
[7]于德新,李传福.肝铁过载及MRI无创评估研究进展[J].国际医学放射学杂志,2009,(02).
[8]冷慧敏,骆新民,朱航.小鼠铁过量模型建立及相关指标的观察研究[J].齐鲁医学杂志,2008,(04)：331-334.
[9]Cardin R, D'Errico A, Fiorentino M, et al. Hepatocyte proliferation and apoptosis in relation to oxidative damage in alcohol-related liver disease.[J]. Alcohol,2002, 37(1):43～48.
[10]曹治宸,白玉,杨学农,等.乙型肝炎肝损伤中铁代谢异常的研究[J].中华肝脏 病杂志,2001,(01).
[11]金延方,孙非,岳云龙,等.应用MRS和R2-*半定量法评价服用枫树油对MRI检查的影响[J].中国医学影像技术,2007,(03).
[12]吴冬青,林敏,安红钢,等.火焰原子吸收光谱法测定12种药用植物花中金属元素[J].光谱实验室,2009,(01).
[13]黄聪武,詹海勇,李国平,等.血清铁和血清铁蛋白与病毒性肝炎患者肝纤维化指标的关系[J].铁是人体必需的微量元素。人体内的含铁化合物主要为亚铁血红蛋白、铁蛋白和含铁血黄素,2007,(03).
[14]宋良文,王德文,崔雪梅,et al.铁、牛磺酸和精氨酸对大鼠肝纤维化的影响[J].中华放射医学与防护杂志,1997,17：410-413,R818,R575,R341,R977,R914.
[15]Ishida M, Nakagawara G, Imamura Y, et al. Iron and copper deposition in chronic active hepatitis and liver cirrhosis; pathogenetic role in progressive liver cell damage.[J]. Eur J Histochem,1995,39(3):221～236.
[16]Cable E E, Connor J R, Isom H C. Accumulation of iron by primary rat hepatocytes in long-term culture:changes in nuclear shape mediated by non-transferrin-bound forms of iron.[J]. Am J Pathol,1998,152(3):781～792.
[17]江远,张玲,何金洋,等.在二甲基亚硝胺诱导大鼠肝纤维化时铁超载和脂肪堆积的作用[J].中西医结合肝病,2009,(02).
[1]Tanimoto A, Oshio K, Suematsu M, et al. Relaxation effects of clustered particles. [J]. J Magn Reson Imaging,2001,14(1):72-77.
[2]Alexopoulou E, Stripeli F, Baras P, et al. R2 relaxometry with MRI for the quantification of tissue iron overload in beta-thalassemic patients.[J]. J Magn Reson Imaging,2006,23(2):163～170.
[3]金延方,孙非,岳云龙,等.应用MRS和R2-*半定量法评价服用枫树油对MRI检查的影响[J].中国医学影像技术,2007,(03).
[4]黄自力,黄文才,李国雄.菲力磁增强磁共振诊断急性放射性肝损伤的实验研究[J].华南国防医学杂志,2008,(05)：24-26.
[5]Siegers C P, Bumann D, Trepkau H D, et al. Influence of dietary iron overload on cell proliferation and intestinal tumorigenesis in mice.[J]. Cancer Lett,1992,65(3): 245～249.
[6]汤晴,朱天义.铁缺乏对鼠肝癌发生的抑制作用的研究[J].中国公共卫生,1999,(04).
[7]Rouach H, Fataccioli V, Gentil M, et al. Effect of chronic ethanol feeding on lipid peroxidation and protein oxidation in relation to liver pathology. [J]. Hepatology, 1997,25(2):351-355.
[8]黄聪武,白岚,蔡俊杰,等.血清铁和铁蛋白与肝病患者肝纤维化指标的关系[J].第一军医大学学报,2003,(05)：466-468.
[9]Pinelli A, Trivulzio S, Tomasoni L, et al. High-dose vitamin E lowers urine porphyrin levels in patients affected by porphyria cutanea tarda.[J]. Pharmacol Res, 2002,45(4):355～359.
[10]Bayraktar Y, Koseoglu T, Somner C, et al. The use of deferoxamine infusions to enhance the response rate to interferon-alpha treatment of chronic viral hepatitis B.[J]. J Viral Hepat,1996,3(3):129～135.
[1]高春芳,陆伦根主编,纤维化疾病的基础和临床.In；上海科学技术出版社：上海,2004;p 592
[2]Okazaki I, Watanabe T, Hozawa S, et al. Molecular mechanism of the reversibility of hepatic fibrosis:with special reference to the role of matrix metalloproteinases.[J]. J Gastroenterol Hepatol,2000,15 Suppl:D26～D32.
[3]Okazaki I, Watanabe T, Hozawa S, et al. Reversibility of hepatic fibrosis:from the first report of collagenase in the liver to the possibility of gene therapy for recovery.[J]. Keio J Med,2001,50(2):58-65.
[4]McCrudden R, Iredale J P. Liver fibrosis, the hepatic stellate cell and tissue inhibitors of metalloproteinases.[J]. Histol Histopathol,2000,15(4):1159～1168.
[5]管生,赵卫东,周康荣,等.原发性肝细胞癌癌前病变血液动力学的MR实验研究[J].中华放射学杂志,2006,(03).
[6]张铁宁,张皓,缪竞陶.MR灌注成像在肝脏常见占位性病变诊断及鉴别诊断中的价值初探[J].中国医学影像技术,2006,(12).
[7]Ichikawa T, Haradome H, Hachiya J, et al. Perfusion-weighted MR imaging in the upper abdomen:preliminary clinical experience in 61 patients.[J]. AJR Am J Roentgenol,1997,169(4):1061-1066.
[8]Fujita T, Ito K, Honjo K, et al. Hepatic parenchymal enhancement in the cirrhotic liver:evaluation by triple-phase dynamic MRI.[J]. Abdom Imaging,2002,27(1): 29～33.
[9]胡晓峰,刘斌,钱银锋,等.磁共振灌注成像对肝纤维化的实验性研究[J].放射学实践,2008,(10).
[10]张皓,顾爱华,缪竞陶,等.晚期肝硬化肝脏MR灌注成像的灌注量化分析[J].放射学实践,2006,(12).
[11]管生,赵卫东,周康荣,等.磁共振功能弥散成像对肝脏早期弥漫性病变诊断价值的实验研究[J].中华肝脏病杂志,2005,(07).
[12]Taouli B, Vilgrain V, Dumont E, et al. Evaluation of liver diffusion isotropy and characterization of focal hepatic lesions with two single-shot echo-planar MR imaging sequences:prospective study in 66 patients.[J]. Radiology,2003,226(1): 71～78.
[13]张丽,胡道予,胡学梅,等.MRS和MR-DTI对肝硬化诊断、分级效果的比较[J].中国医学影像技术,2009,(03)：459-461.
[14]Koinuma M, Ohashi I, Hanafusa K, et al. Apparent diffusion coefficient measurements with diffusion-weighted magnetic resonance imaging for evaluation of hepatic fibrosis.[J]. J Magn Reson Imaging,2005,22(1):80～85.
[15]Aube C, Racineux P X, Lebigot J, et al. [Diagnosis and quantification of hepatic fibrosis with diffusion weighted MR imaging:preliminary results][J]. J Radiol,2004, 85(3):301～306.
[16]王秋实,郭启勇,梁长虹,等.MR弥散加权成像评价肝纤维化的初步实验研究[J].解剖学研究,2007,(03).
[17]杨正汉,谢敬霞,胡碧芳,等.肝硬化组织表观扩散系数改变及其可能机制的实验研究[J].中国医学影像技术,2002,(09).
[18]王宏伟.磁化传递成像技术与神经系统疾病[J].国外医学临床放射学分册,2002,(03)：144-148.
[19]Chen J H, Chai J W, Shen W C. Magnetization transfer contrast imaging of liver cirrhosis.[J]. Hepatogastroenterology,1999,46(29):2872～2877.
[20]Hollett M D, Aisen A M, Yeung H N, et al. Magnetization transfer contrast imaging of hepatic neoplasms.[J]. Magn Reson Imaging,1994,12(1):1～8.
[21]马国林,沈文,张学滨,等.肝纤维化和肝硬化磁化传递成像与血清学指标相关性研究[J].实用放射学杂志,2009,
[22]Bieri O, Maderwald S, Ladd M E, et al. Balanced alternating steady-state elastography.[J]. Magn Reson Med,2006,55(2):233～241.
[23]Suga M, Matsuda T, Minato K, et al. Measurement of in vivo local shear modulus
using MR elastography multiple-phase patchwork offsets. [J]. IEEE Trans Biomed Eng,2003,50(7):908-915.
[24]Manduca A, Oliphant T E, Dresner M A, et al. Magnetic resonance elastography: non-invasive mapping of tissue elasticity.[J]. Med Image Anal,2001,5(4):237～ 254.
[25]Rouviere O, Yin M, Dresner M A, et al. MR elastography of the liver:preliminary results.[J]. Radiology,2006,240(2):440-448.
[26]Huwart L, Peeters F, Sinkus R, et al. Liver fibrosis:non-invasive assessment with MR elastography.[J]. NMR Biomed,2006,19(2):173-179.
[27]田艳,范竹萍,顾海燕.磁共振技术对脂肪性肝病诊断的进展[J].世界华人消化杂志,2007,(24).
[28]Orlacchio A, Bolacchi F, Angelico M, et al. In vivo, high-field,3-Tesla 1H MR spectroscopic assessment of liver fibrosis in HCV-correlated chronic liver disease.[J]. Radiol Med,2008,113(2):289～299.
[29]Cho, Gu S, Kim M Y, et al. Chronic Hepatitis:In Vivo Proton MR Spectroscopic Evaluation of the Liver and Correlation with Histopathologic Findings[J]. Radiology, 2001,221(3):740～746.
[30]Noren B, Dahlqvist O, Lundberg P, et al. Separation of advanced from mild fibrosis in diffuse liver disease using 31P magnetic resonance spectroscopy.[J]. Eur J Radiol, 2008,66(2):313～320.
[31]于德新,马祥兴,李笃民,等.～(31)P-MRS在评估肝硬化及其分级中的价值[J].临床放射学杂志,2009,(07).
[32]Dezortova M, Taimr P, Skoch A, et al. Etiology and functional status of liver cirrhosis by 31P MR spectroscopy.[J]. World J Gastroenterol,2005,11(44):6926～ 6931.
[33]Menon D K, Harris M, Sargentoni J, et al. In vivo hepatic 31P magnetic resonance spectroscopy in chronic alcohol abusers.[J]. Gastroenterology,1995,108(3):776～ 788.
[34]黄聪武,白岚,蔡俊杰,等.血清铁和铁蛋白与肝病患者肝纤维化指标的关系[J].第一军医大学学报,2003,(05)：466-468.
[35]Alexopoulou E, Stripeli F, Baras P, et al. R2 relaxometry with MRI for the quantification of tissue iron overload in beta-thalassemic patients. [J]. J Magn Reson Imaging,2006,23(2):163～170.
[36]Tanimoto A, Oshio K, Suematsu M, et al. Relaxation effects of clustered particles.[J]. J Magn Reson Imaging,2001,14(1):72～77.
[37]Gandon Y, Olivie D, Guyader D, et al. Non-invasive assessment of hepatic iron stores by MRI.[J]. Lancet,2004,363(9406):357～362.